New patient enrolled into Invivo Therapeutics INSPIRE study

147
Invivo Therapeutics’ Neuro-spinal scaffold

A new patient has been enrolled into Invivo Therapeutics’ INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-spinal scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury).

Travis Dumont, an INSPIRE principal Investigator, performed the implantation on January 16, 2017, approximately 67 hours after the injury occurred.

“The implantation procedure of the Neuro-spinal scaffold was successful, and the patient is doing well,” Dumont says. “I look forward to following the patient’s progress going forward.”

Mark Perrin, Invivo’s chief executive officer and chairman, says, “We are pleased at the rate of enrollment into INSPIRE over the past few months. We now have eleven patients enrolled and in follow up, and with a steady flow of new sites we expect enrollment to increase in the coming months.”